Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 4 Next >
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Completes Acquisition of Abiomed
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Abiomed
From Johnson & Johnson
Via Business Wire
Tickers ABMD JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2022
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q3 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces $5 Billion Share Repurchase Program
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q2 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.